TGTX

TG THERAPEUTICS INC

Healthcare | Mid Cap

$0.24

EPS Forecast

$201.2

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

$0.24

Revenue Forecast:

$201.2

EPS Surprise Forecast:

-$0.005

Revenue Surprise Forecast:

$2

Post-release price volatility - High

Post-release Overnight Move:

±9.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

51%

Probability of beating revenue consensus:

59%

Probability of beating both EPS & revs consensus:

37%

Probability of missing both EPS & revs consensus:

27%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-3

Beta (β)

Forward Looking Beta (β):

1.09

Earnings volatility

EPS standard deviation:

$0.19

Revenue standard deviation:

$21

As % of share price:

0.62% VERY HIGH

As % of market cap:

0.43% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.50

Revenue 95th %ile:

$229

EPS 75th %ile:

$0.31

Revenue 75th %ile:

$209

EPS 25th %ile:

$0.19

Revenue 25th %ile:

$195

EPS 5th %ile:

$0.04

Revenue 5th %ile:

$178

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

44% HIGH

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

64% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$18

Bid-ask per Share:

$0.055